Tympanogen
PrivateLast Round
Series A
Mar 13, 2025
Total Funding Raised
$7.47M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Tympanogen is a medical device company that develops innovative, nonsurgical solutions for ear, nose, and throat (ENT) conditions, including its flagship Perf-Fix™ gel patch for eardrum repair.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tympanogen Comparables
Compare Tympanogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TymCure Ltd. | 87% | |
| Innovia Medical | 80% | |
| Noviotissue | 78% |
Tympanogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 13, 2025 | ||||
| Grant | Jul 25, 2023 | ||||
| Debt | Mar 1, 2022 | ||||
| Grant | Nov 1, 2021 | ||||
| Grant | Jun 17, 2020 | ||||
Grant | Jan 7, 2020 |
Tympanogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Activation Capital | Grant |
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| ShockVentures | Debt |
| CAV Angels | Debt, Series A |
| Virginia Innovation Partnership Corporation | VC Round |
| Virginia Venture Partners | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 703% MoM, reaching 1.3K.
- Mar 13, 2025
$1.48M round led by Keiretsu Forum Mid-Atlantic.
Tympanogen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tympanogen's valuation, stock price, and market status.
Is Tympanogen a public or private company?
Tympanogen is a private company.
What is the current stock price of Tympanogen?
Tympanogen is a private company with no public stock price. No recent secondary market data is available.
How much is Tympanogen worth (valuation)?
Valuation information for Tympanogen is not publicly available.
Can I buy Tympanogen stock?
Tympanogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tympanogen's last funding round?
Tympanogen's most recent funding round was Series A on July 30, 2025.
Who are the main investors in Tympanogen?
Key investors in Tympanogen include Keiretsu Forum Mid-Atlantic.
Will Tympanogen IPO soon?
No public IPO plans have been announced for Tympanogen.
How can I track Tympanogen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tympanogen's secondary market activity and sign up for updates.